Search results
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 4 days agovaccine for adults ages 60 and older. This will be the only RSV vaccine available in single-dose...
Moderna wins second product approval with RSV vaccine
Market Watch· 5 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Digital Journal· 5 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE ...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Colorado Springs Gazette· 6 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
US nears deal to fund Moderna’s bird flu vaccine trial, FT reports
KFGO· 6 days ago(Reuters) - The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 5 days agoAll three have occurred since April 1. Two of the patients were in Michigan. A Moderna spokeswoman...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports By Reuters
Investing.com· 6 days agoModerna and the U.S. Department of Health and Human Services (HHS) did not...talks with CSL...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 2 days agoThe RSV vaccine will now be reviewed at the CDC's Advisory Committee on Immunization Practices...
Moderna wins second product approval with RSV vaccine
Morningstar· 5 days agoModerna Inc.'s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a ...
Moderna's RSV Vaccine Approved by FDA
Medscape· 2 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.